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Antibacterial treatment with cotrimoxazol (TxS), a combination of trimethoprim and
sulfamethoxazole, generates resistance by, among others, acquisition of thymidine
auxotrophy associated with mutations in the thymidylate synthase gene thyA, which can
modify the biology of infection. The opportunistic pathogen non-typeable Haemophilus
influenzae (NTHi) is frequently encountered in the lower airways of chronic obstructive
pulmonary disease (COPD) patients, and associated with acute exacerbation of COPD
symptoms. Increasing resistance of NTHi to TxS limits its suitability as initial antibacterial
against COPD exacerbation, although its relationship with thymidine auxotrophy is
unknown. In this study, the analysis of 2,542 NTHi isolates recovered at Bellvitge
University Hospital (Spain) in the period 2010–2014 revealed 119 strains forming slow-
growing colonies on the thymidine low concentration medium Mueller Hinton Fastidious,
including one strain isolated from a COPD patient undergoing TxS therapy that was
a reversible thymidine auxotroph. To assess the impact of thymidine auxotrophy in
the NTHi-host interplay during respiratory infection, thyA mutants were generated in
both the clinical isolate NTHi375 and the reference strain RdKW20. Inactivation of
the thyA gene increased TxS resistance, but also promoted morphological changes
consistent with elongation and impaired bacterial division, which altered H. influenzae
self-aggregation, phosphorylcholine level, C3b deposition, and airway epithelial infection
patterns. Availability of external thymidine contributed to overcome such auxotrophy
and TxS effect, potentially facilitated by the nucleoside transporter nupC. Although,
thyA inactivation resulted in bacterial attenuation in a lung infection mouse model, it
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also rendered a lower clearance upon a TxS challenge in vivo. Thus, our results show
that thymidine auxotrophy modulates both the NTHi host airway interplay and antibiotic
resistance, which should be considered at the clinical setting for the consequences of
TxS administration.
Keywords: Haemophilus influenzae, thymidylate synthase, thymidine auxotrophy, thymidine uptake, bacterial
morphology, antibiotic resistance, airway infection
INTRODUCTION
Non-typeable (non-capsulated) Haemophilus influenzae
(NTHi) is a Gram negative coccobacillus that is a common
commensal in the nasopharynx of healthy humans, and also
an opportunistic pathogen causing respiratory infections such
as acute otitis media, otitis media with effusion, community-
acquired pneumonia, and exacerbations of chronic obstructive
pulmonary disease (COPD; Agrawal and Murphy, 2011).
COPD is characterized by a progressive and not fully reversible
airflow limitation, accompanied by infiltration of the airways
by neutrophils and mucus hypersecretion (Barnes, 2016). The
chronic course and evolution of COPD is often characterized by
periods of symptom exacerbation with a negative impact on the
patient’s quality of life and evolution of the disease, and represent
a significant cause of medical intervention and hospitalization.
Given that acute exacerbations of COPD (AECOPD) are mostly
caused by bacterial and viral infections (Sethi, 2010), antibiotic
therapy is routinely prescribed. Use of amoxicillin, tetracyclines,
or cotrimoxazole (TxS), a combination of trimethoprim (TMP)
and sulfamethoxazole (SMX), has long been regarded as standard
therapy for patients with AECOPD, which has contributed to
the increasing emergence of resistance to these antibiotics in
common respiratory pathogens such as NTHi, and become a real
challenge in the choice of adequate antibacterials (Nouira et al.,
2010).
The treatment of respiratory infections has been a very
important field of use of TxS, as a first-line agent against H.
influenzae infected respiratory patients (Iyer Parameswaran and
Murphy, 2009), and has also been considered as a prophylactic
option in HIV-infected children therefore having an impact on
H. influenzae carriage (Grant et al., 2009; Mwenya et al., 2010),
altogether increasing TxS resistance levels in this pathogen.
TxS interferes with the bacterial metabolism and replication by
blocking the production of tetrahydrofolic acid (THF). THF is
a co-factor for the thymidylate synthase, an essential protein
encoded by the thyA gene, required for the conversion of
thymidine from uracil (Stryer, 1995). During normalmetabolism,
dihydrofolate is reduced to THF by the dihydrofolate reductase
(DHFR), encoded by the folH gene, also known as drfA and
folA. TMP is a substrate analog of dihydrofolate and blocks
its reduction to THF. Conversely, SMX is a substrate analog
of para-aminobenzoic acid, and blocks the folP gene encoding
the dihydropteroate synthetase DHPS, which is involved in
production of dihydropteroate, a precursor of dihydrofolate.
Both TMP and SMX have little toxicity to humans because
humans do not synthesize folic acid but obtain it from dietary
sources (Tristram et al., 2007). Inhibiting the production of THF
prevents thymine synthesis and, hence, DNA replication, causing
bacterial death and TxS susceptibility. However, if external
thymidine is available, as shown in infected tissues (Besier et al.,
2008), thymidine-dependent TxS resistance may emerge upon
treatment. This aspect has been long reported (Maskell et al.,
1978), and extensively analyzed in Staphylococcus aureus, where
the underlying mechanism for thymidine dependency relies on
mutations of the thyA gene. Thus, inactivation of the thyA gene
generates thymidine auxotroph small colony variants (SCVs)
with a strong impact in this pathogen’s physiology, virulence, and
persistence, and uptake of external thymidine by the S. aureus
NupC nucleoside transporter seems to bypass the effect of TxS
(Kriegeskorte et al., 2014).
In NTHi, resistance to TxS is associated to polymorphisms
and/or short insertions in the folH and folP genes, DHFR
overproduction, or acquisition of the sulfonamide (SUL) genes
sul1 and sul2 (de Groot et al., 1988, 1996; Enne et al., 2002).
Existing evidence also relates H. influenzae TMP resistance
to transient thymidine auxotrophy in isolates from sputum
samples of chronic bronchitis patients receiving TMP (Platt
et al., 1983). Despite this observation, little is known about
thymidine-dependent antibiotic resistance and its underlying
consequences for NTHi pathogenesis. Following this notion, we
observed that among 2,542 NTHi strains isolated between 2010
and 2014 from clinical samples at Bellvitge University Hospital
(Spain), 119 strains formed slow-growing colonies on Mueller
Hinton Fastidious (MH-F) agar, a thymidine low concentration
medium. This observation prompted us to hypothesize that such
slow-growth could relate to thymidine auxotrophy, rendering
TxS resistance due to the antibiotic administration. If so, such
auxotrophy could also modify the dynamics of the NTHi-
host interplay. To address these hypotheses, we screened the
available NTHi isolates with a slow growth on MH-F agar
and identified one thymidine auxotroph, easily reversible to
the normal phenotype. Moreover, to question the relationship
between thymidine auxotrophy and respiratory infection by
NTHi, we employed two genome sequenced strains, NTHi
strain 375, hereafter NTHi375, and H. influenzae (Hi) RdKW20
(Fleischmann et al., 1995;Mell et al., 2014), to generate thymidine
auxotrophs by mutating the thyA gene, and systematically
evaluated its effect on (i) bacterial resistance to TxS, morphology,
growth, self-aggregation, and gene expression; (ii) NTHi-host
interplay by assessing bacterial binding to a panel of components
of the complement system, adhesion to- and invasion of cultured
airway epithelia; (iii) NTHi respiratory infection in vivo by using
a murine intranasal infection model upon TxS treatment. This
work provides further evidence of the emergence of NTHi TxS
resistance upon its administration, and shows for the first time
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that mutation of the thymidylate synthase encoding gene thyA in
NTHi leads to a strong impact on its physiology and virulence,
but also provides a survival advantage during TxS challenge.
Our results provide a context for a better understanding of
the potential effects of TxS treatment against NTHi respiratory
infection.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Strains used in this study are described in Table 1. NTHi strains
were grown at 37◦C, 5% CO2 on chocolate agar (Biomérieux),
MH-F agar (Biomérieux), or brain-heart infusion (BHI) agar
supplemented with 10 µg/ml hemin and 10 µg/ml nicotinamide
adenine dinucleotide (NAD), referred to as sBHI. NTHi liquid
cultures were grown in sBHI (37◦C, 5% CO2). Thymidine
(Sigma-Aldrich) was dissolved in sterile distilled water (stock
solution, 10 mg/ml). When necessary, media were supplemented
with thymidine by (i) using sterile paper discs soaked on
thymidine 300 µg/ml or 10 mg/ml, (ii) thymidine 300 µg/ml
spreading on 20 ml chocolate agar or MH-F agar plates, (iii)
thymidine 300 µg/ml addition into sBHI. Erythromycin 11
µg/ml (Erm11) or spectinomycin 50 µg/ml (Spec50) were used
when required. Escherichia coli was grown on Luria Bertani (LB)
agar at 37◦C, supplemented with ampicillin 100µg/ml (Amp100),
erythromycin 150 µg/ml (Erm150) or Spec50, when necessary.
For thyA disruption, a DNA fragment containing the thyA
gene and its respective adjacent regions (2,852 bp), was PCR
amplified with Phusion polymerase (Thermofisher) using
NTHi375 genomic DNA as template and primers thyA-F1 (5′-
TGCCTGAATATTCGCTCGGTTACATTTA) and thyA-R1 (5′-
CGATGATACTTAAAAGTAATCGCGACCAAAAATTCGG).
The gene-containing fragment was cloned into pJET1.2
(Thermofisher), generating pJET1.2-thyA. This cloned
PCR product was disrupted by inverse PCR with
Phusion polymerase, using primers thyA-F2 (5′-
CGTTCCTGTGATGTTCCGCTTGGA) and thyA-R2
(5′-ATATCATCAACGCCTCTACGATGC). An internal
226-bp fragment (nucleotides 312–537 in the thyA coding
sequence) was replaced by a blunt-ended erythromycin
resistance cassette excised by SmaI digestion from pBSLerm
(Allen et al., 2005), generating pJET1.2-thyA::ermC. This
plasmid was used as a template to amplify the thyA::ermC
disruption cassette with primers thyA-F1 and thyA-R1, which
was used to transform NTHi375 using the MIV method
(Herriott et al., 1970). Transformants were screened by plating
bacteria on sBHI agar with Erm11 to obtain NTHi3751thyA.
Same approach and disruption cassette were used to generate
RdKW201thyA. For mutant confirmation, NTHi3751thyA
and RdKW201thyA genomic DNA were used as template
to be PCR amplified with four primer pairs: (i) thyA-F1 and
thyA-R1, rendering a 3,814 bp product; (ii) thyA-F1 and
pBSLerm-down (5′-GGTACACGAAAAACAAGTTAAGGG),
rendering a 2,421 bp product; (iii) pBSLerm-up (5′-
ATAAAGAGGGTTATAATGAACGAG) and thyA-R1, rendering
a 2,190 bp product; (iv) pBSLerm-up and pBSLerm-down,
rendering a 797 bp product (data not shown). Recombination
events resulting from integration of the thyA disruption
TABLE 1 | Strains and plasmids used in this study.
Description Source
STRAINS
Haemophilus influenzae
NTHi375 Wild-type, otitis media clinical isolate Hood et al., 1999
NTHi3751thyA thyA::ermC, ErmR This study
NTHi3751nupC nupC::spec, SpecR This study
RdKW20 Laboratory strain, capsule-deficient serotype d Fleischmann et al.,
1995
RdKW201thyA thyA::ermC, ErmR This study
RdKW201nupC nupC::spec, SpecR This study
NTHi8233 COPD isolate from a sputum sample, thymidine auxotroph This study
Escherichia coli
TOP 10 Used for cloning assays Thermofisher scientific
SW102 Derived from DY380, it contains a defective λ prophage with the recombination
proteins exo, bet, and gam being controlled by the temperature-sensitive repressor cI857
Tracy et al., 2008
PLASMIDS
pJET1.2 Cloning vector Thermofisher scientific
pBSLerm Source of an ErmR cassette Allen et al., 2005
pJET1.2-thyA pJET1.2 with a 2,852 bp insert containing the thyANTHi375 gene (852 bp) and 1 kb flanking regions This study
pJET1.2-thyA::ermC pJET1.2 with a 3,814 bp insert containing a thyANTHi375::ermC disruption cassette This study
pJET1.2-nupC pJET1.2 with a 2,664 bp insert containing the nupCRdKW20 gene (1,254 bp) gene and ∼700 bp flanking regions This study
pJET1.2-nupC::spec pJET1.2 with a 3,501 bp insert containing a nupCRdKW20::spec disruption cassette This study
pRSM2832 pKD13 derivative carrying a cassette containing a spectinomycin resistance gene flanked by FRT sites Tracy et al., 2008
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cassette in the NTHi375 and RdKW20 genomes were
further verified by NTHi3751thyA and RdKW201thyA
genomic DNA PCR amplification with primers thyA-F1
and thyA-R1, and PCR product sequencing with primers
thyA-F1, pBSLerm-up, pBSLerm-down and thyA-R1. When
necessary, the thyA gene was PCR amplified with primers
ThyA_Pro_F (5′-TGCGCCTTTGATTCCGTTTG) and
ThyA_R2 (5′-TCACCTAACGCTTCCGCTTT) for DNA
sequencing.
The nupC gene and its respective adjacent regions (2,664
bp) was amplified by PCR with Phusion polymerase using
RdKW20 genomic DNA as template and primers nupC-F1
(5′-ATGAACAGGTTATGGAGGCAGTTCCAT) and nupC-R1
(5′-GTGAGTACGAATATGGTCAGACACGGT). The gene-
containing fragment was cloned into pJET1.2, generating
pJET1.2-nupC. A Specr cassette was PCR amplified from
pRSM2832 using gene-specific mutagenic primers nupC-F2
(5′-GTAGAATAAGCCGAATTTTATTAACTTAACTAAT
CTAGGGGAATCAAATGATTCCGGGGATCCGTCGACC)
and nupC-R2 (5′-TACCGCACTTTTTAATTGATTAAGATA
AATTAAAGTGCTGCAGCACCTAAGCCTGTAGGCTGG
AGCTGCTTCG), as described previously (Tracy et al., 2008).
Primers were designed to delete sequences between the start
codon and the last seven codons of nupC. E. coli SW102 cells
were prepared for recombineering, co-electroporated with
pJET1.2-nupC (Ampr; 50 ng) and the nupC-specific mutagenic
cassette (Specr; 200 ng) as previously described (Sinha et al.,
2012), and mutagenized clones containing pJET1.2-nupC::spec
were selected on LB agar with Amp100, Spec50. This plasmid
was used as a template to amplify the nupC::spec disruption
cassette with primers nupC-F1 and nupC-R1, which was used
to transform NTHi375 and RdKW20 using the MIV method.
Transformants were selected on sBHI agar with Spec50, to obtain
NTHi3751nupC and RdKW201nupCmutant strains.
Screening for NTHi Thymidine Auxotroph
Clinical Isolates
Laboratory records of Microbiology Department at the Bellvitge
University Hospital (Spain) regarding the difficulties of some
NTHi isolates to growth on conventional antimicrobial
susceptibility testing medium (Mueller-Hinton agar+5%
defibrinated horse blood and 20 mg/l β-NAD, MH-F) were
reviewed from 2010 to 2014. Screening for thymidine auxotrophs
among NTHi clinical isolates was based on the interpretation of
their growth characteristics. Isolates identified as having growth
problems were further screened for thymidine auxotrophy by
comparative growth on chocolate agar plates and low-thymidine
MH-F agar plates. Thymidine auxotrophy was confirmed by
testing strain growth on MH-F agar in the absence or presence of
discs soaked with thymidine.
Susceptibility Testing under Non-standard
Conditions
TxS susceptibility testing of NTHi thymidine auxotrophs failed
to produce results by disc diffusion (Becton Dickinson), E-test
(Biomérieux) or broth microdilution when inoculated on MH-F
and incubated for 24 h, as specified by the European Committee
on Antimicrobial Susceptibility Testing (EUCAST; http://
www.eucast.org/clinical_breakpoints). Given that chocolate agar
supported growth for all strains after 24 h of incubation, this
medium was used for E-test- or TxS discs-based determination
of minimal inhibitory concentrations (MIC). Strains were grown
on chocolate agar, to generate bacterial suspensions normalized
in phosphate-buffered saline (PBS) to OD600 = 1. Normalized
suspensions were spread on chocolate agar or, when necessary,
on MH-F agar, in the presence of E-test or TxS discs (23.75
mg/1.25mg SMX:TMP) and incubated for 24 h before assessing
the diameter of the growth inhibition zones.
Growth Curves
Tomonitor growth, NTHi strains grown on chocolate agar for 16
h were inoculated (2–5 colonies) in 20 ml sBHI, with or without
thymidine, and incubated for 11 h with shaking. Cultures were
diluted in 40 ml sBHI, with or without thymidine, to OD600 =
0.01 (RdKW20) or OD600 = 0.05 (NTHi375), incubated with
agitation, and OD600 was recorded every hour for 8 h. Every
2 h, culture samples were serially diluted and plated on sBHI
agar. Data are shown both as OD600 and c.f.u./ml. At the final
time point, 10 µl of the bacterial cultures were placed on glass
coverslips and fixed with 3.7% paraformaldehyde (PFA) in PBS
pH 7.4 for 15 min at room temperature. Bacteria were labeled
with a polyclonal rabbit anti-NTHi primary antibody diluted
1:600 and a donkey anti-rabbit conjugated to Cy2 (Jackson
Immunological) secondary antibody diluted 1:100. Samples
were analyzed with a Carl Zeiss Axioskop 2 plus fluorescence
microscope and a Carl Zeiss Axio Cam MRm monochrome
camera.
Confocal Microscopy
NTHi strains were grown on chocolate agar for 16 h, in the
absence or presence of thymidine, and a colony was aseptically
spread with an inoculation loop over a drop of distilled water on a
microscopy slide. Samples were air-dried and stained for 15 min
in the darkness with the cell-permeable fluorescent nucleic acid
stain SYTO 9 (Life Technologies), following the manufacturer’s
instructions. Samples were washed twice with distilled water and
fluorescence was observed by confocal laser microscopy. Images
were acquired using a Leica TCS-SL filter-free spectral confocal
laser-scanning microscope (Leica Microsystems) equipped with
a 488 nm argon laser, 543 nm and 633 nm He/Ne lasers (Centres
Científics i Tecnològics-Campus de Bellvitge, Universitat de
Barcelona, Spain) using a 63× magnification oil immersion
objective (1.4 numerical aperture), and an image resolution of
1024× 1024 pixels. Images were acquired randomly and analyzed
using the Leica Confocal Software 2.5 (Leica Microsystems).
Transmission Electron Microscopy (TEM)
H. influenzae strains were examined by TEM after growth
on chocolate agar following established procedures (Remuzgo-
Martinez et al., 2015). Briefly, bacteria were applied to
Formvar-coated grids, air dried, negatively stained with 1%
phosphotungstic acid in distilled water for 10 s, and examined
with a JEM-1011 transmission electron microscope (JEOL)
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operating at 80 kV and equipped with an Orius SC1000 charge-
coupled device (CCD) camera (Gatan).
RNA Extraction and Real-Time
Quantitative PCR (RT-qPCR) Analysis
NTHi strains were grown for 16 h on chocolate agar. Bacteria
(2–5 colonies) were inoculated into 20 ml sBHI, grown
for 11 h, with or without thymidine, diluted into 40 ml
fresh sBHI to OD600 = 0.05, in the absence or presence
of thymidine, and grown to OD600 = 0.6. Bacterial total
RNA was isolated using TRIzol reagent (Invitrogen). Total
RNA quality was evaluated using RNA 6000 Nano LabChips
(Agilent 2100 Bioanalyzer). All samples had intact 16S and
23S ribosomal RNA. Complementary DNA (cDNA) was
synthesized from total RNA (1 µg) using SuperScript II Reverse
Transcriptase reagents (Invitrogen). Real-time quantitative PCR
was performed using Thermo Scientific Luminaris HiGreen
qPCR Master Mix (Thermo Scientific) and fluorescence data
were analyzed with BioRad CFX96 qPCR System (Bio-Rad).
Relative quantities of mRNAs were calculated using the
comparative threshold cycle (Ct) method and normalized
using 16S ribosomal RNA (16SrRNA) as an endogenous
control. Primer pairs were designed with Primer3 software: for
nupC, nupC-RT-Fw (5′-ATGTTAATCGCATTCGTTGGTT)
and nupC-RT-Rv (5′-ATTTGTCCTGCAATACCTGCTT);
for tdk, tdk-RT-Fw (5′-TGTGCTTTGTTATGGCTTGC) and
tdk-RT-Rv (5′-CTTTAATGACCTCGCCCTGA); for 16SrRNA,
16S-Fw (5′-GGCGTTGATGACCGTGAAAC) and 16S-Rv (5′-
GCCAGTAATAATCGCCCTCTTCTAG). Data are expressed as
relative expression on mutant strains compared to their parental
wild-type strains, considered to be 1. All measures were carried
out in duplicate and at least three times (n ≥ 6).
Bacterial Aggregation Assay
Three to four colonies of NTHi grown on chocolate agar for
16 h were inoculated into 20 ml sBHI, grown for 11 h, diluted
in sBHI to OD600 = 1 and left standing at room temperature
for 5 h (starting volume ∼25 ml). The viability of each culture
was tested by serial dilution and plating on sBHI agar at the
beginning of each experiment (t = 0; data not shown). OD600
readings were performed at regular time intervals on 700 µl
aliquots collected from the top of each bacterial suspension. At
least four independent experiments (n ≥ 4) were performed for
each strain.
Phosphorylcholine (PCho) Quantification
Three to four colonies of NTHi grown on chocolate agar for
16 h were inoculated into 20 ml sBHI, grown for 11 h, diluted
into 40 ml sBHI to OD600 = 0.05, grown to OD600 = 0.6 in
the absence or presence of thymidine, serially diluted, plated
on sBHI agar for c.f.u. determination, and used to generate
stocks stored at −80◦C in sBHI with 20% glycerol as single use
aliquots for further experiments. For PCho determination, ∼1
× 107 c.f.u. were incubated for 1 h at 37◦C with TEPC-15, a
mouse monoclonal antibody specific for PCho (Sigma-Aldrich)
diluted 1:25 in PBS-0.05% Tween 20. Samples were washed twice
with PBS-0.05% Tween 20, and incubated with a fluorescein
isothiocyanate (FITC)-conjugated rabbit anti-mouse (Serotec)
diluted 1:300 in PBS-0.05% Tween 20 for 30 min at 4◦C under
dark conditions. Bacteria were washed with PBS-0.05% Tween
20, fixed in 3% paraformaldehyde (PFA) for 2–3 min at room
temperature, and analyzed on a FACSCalibur flow cytometer
(BD Biosciences) using forward and side scatter parameters
to gate on at least 25,000 bacteria. Results are expressed as a
relative percent fluorescence index (RFI), to measure both the
proportion of fluorescent bacteria positive for PCho and the
intensity of fluorescence (Ramos-Sevillano et al., 2015). Assays
were performed in quadruplicate in at least three independent
occassions (n ≥ 12).
Binding of Complement Factors to NTHi
Bacterial strains were grown as indicated for PCho
determination. C3b deposition was analyzed as explained
previously (Ramos-Sevillano et al., 2015). Briefly, a bacterial
suspension containing ∼1 × 107 c.f.u. was opsonized with
human serum diluted 1:4 in PBS-0.05% Tween 20, and detected
with a FITC-conjugated polyclonal goat anti-human C3b
antibody (ICN-Cappel) diluted 1:300 in PBS-0.05% Tween 20
for 30 min at 4◦C under dark conditions. CRP binding was
measured as previously described (Ramos-Sevillano et al., 2015),
by incubating ∼1 × 107 c.f.u. with human serum diluted 1:4 in
PBS-0.05% Tween 20 and detected with a polyclonal rabbit anti-
human CRP antibody (Calbiochem) for 1 h at 37◦C, followed
by two washes with PBS-0.05% Tween 20. Bacterial suspensions
were then incubated for 30 min with a FITC-conjugated
polyclonal goat anti-rabbit antibody in PBS-0.05% Tween 20
for 1 h at 37◦C. For both C3b and CRP binding, bacteria were
finally washed with PBS-0.05% Tween 20, fixed in 3% PFA,
and analyzed on a FACSCalibur flow cytometer as described
above. Results are expressed as a RFI. Assays were performed in
quadruplicate in at least three independent occassions (n ≥ 12).
Cell Culture and Bacterial Infection
A549 human alveolar basal epithelial cells (ATCCCCL-185) were
maintained as described (Morey et al., 2011), seeded to 6 ×
104 cells/well for 32 h, and serum-starved 16 h before infection.
NCI H-292 mucoepidermoid pulmonary human carcinoma
epithelial cells (ATCC CRL-1848) were maintained as described
(Euba et al., 2015c), and seeded to 4 × 105 cells/well 16 h
before infection. Adhesion and invasion assays were performed
and processed as described (Morey et al., 2011; Lopez-Gomez
et al., 2012; Euba et al., 2015a,c). For infection, PBS-normalized
bacterial suspensions (OD600 = 1) were prepared by using NTHi
strains grown on chocolate agar for 16 h, or in 20 ml sBHI for
11 h in the absence or presence of thymidine. A multiplicity
of infection (MOI) of ∼100:1 was used. To monitor adhesion,
cells were infected for 30 min. Although this assay does not
completely exclude a possible internalization of some bacteria,
experimental conditions were previously set to mainly monitor
adhesion (Morey et al., 2011; data not shown). For invasion
assays, cells were incubated with bacteria for 2 h, washed three
times with PBS, incubated for 1 h with RPMI 1640 medium
containing 10% FCS, Hepes 10 mM, and gentamicin 200 µg/ml
to kill extracellular bacteria.
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When necessary, A549 cells were infected for 30 min with
bacterial suspensions (OD600 = 1) generated with bacteria grown
on chocolate agar, in the absence or presence of thymidine;
infections were performed in RPMI 1640, and in the absence
or presence of purified C3 (16 µg/ml), 2% C3-deficient human
serum (HS), or C3-depleted HS reconstituted with purified C3.
Human C3-deficient serum and human complement C3 were
purchased from Sigma-Aldrich. Cells were then washed three
times with PBS, lysed with 300 µl of PBS-saponin 0.025% for
10 min at room temperature, and serial dilutions were plated
on sBHI agar. All infections were performed in triplicate at
least three independent times (n ≥ 9). Results are expressed as
c.f.u./ml.
Secretion of IL-8
For A549 cell stimulation by NTHi, bacteria grown on chocolate
agar, in the absence or presence of thymidine, were collected with
PBS, suspensions were normalized to OD600 = 1, and used for
a 2 h infection with a MOI of ∼100:1. Cells were washed three
times with PBS, and incubated for 6 h in RPMI 1640 medium
containing 10% FCS, Hepes 10 mM and gentamicin 100 µg/ml.
Supernatants were collected from the wells, cell debris removed
by centrifugation and samples frozen at –80◦C. IL-8 levels in the
supernatants were measured by ELISA (Abnova KA0115) with
sensitivity<2 pg/ml. Infections were performed in duplicate and
at least twice (n ≥ 4). Results are expressed as IL-8 pg/ml.
Scanning Electron Microscopy (SEM)
A549 cells were seeded on glass coverslips and infected as
described above, by using bacteria previously grown on chocolate
agar. Coverslips were fixed in ice-cold 3% glutaraldehyde for
20 min at 4◦C. Samples were dehydrated in a series of graded
acetone, dried by the critical point method, coated with gold in
a Fine coat ion sputter JFC-1100 226 (JEOL, Ltd) and observed
with an Inspect S microscope (FEI Company) working at 15 or
20 kV (Lazaro-Diez et al., 2016).
NTHi Mouse Lung Infection
A CD1 mouse model of NTHi lung infection was used, as
described previously (Morey et al., 2013; Euba et al., 2015a,b,c).
CD1 female mice (18–20 g) aged 4–5 weeks were purchased
from Charles River Laboratories (France), housed under
pathogen-free conditions at the Institute of Agrobiotechnology
facilities (registration number ES/31-2016-000002-CR-SU-US),
and used at 22–25 g. Animal handling and procedures
were in accordance with the current European (Directive
86/609/EEC) and National (Real Decreto 53/2013) legislations,
following the FELASA and ARRIVE guidelines, and with the
approval of the Universidad Pública de Navarra (UPNa) Animal
Experimentation Committee (Comité de Ética, Experimentación
Animal y Bioseguridad) and the local Government authorization.
NTHi375 and NTHi3751thyA were used for lung infection,
and mice were randomly divided into two groups (n = 5):
(i) control, vehicle solution (0.1 ml PBS) administered by
oroesophageal gavage (Popper & Sons Inc.); (ii) one dose of TxS
each 6 h administered by oroesophageal gavage, starting at 6 h
post-infection (hpi). TxS (Septrin, 8 mg/40 mg/ml TMP:SMX)
treatment was performed at a dose of 960 mg/kg of body
weight in 0.1 ml PBS. Infecting bacteria were previously grown
on chocolate agar, in the absence or presence of thymidine.
For NTHi intranasal infection, 40 µl of a NTHi suspension
containing∼5×108 c.f.u./ml (∼2×107 c.f.u./mouse) were placed
at the entrance of the nostrils until complete inhalation, in
mice previously anesthetized with ketamine-xylazine (3:1). At 12,
24, or 48 hpi, mice were euthanized using cervical dislocation.
BALF samples were obtained by perfusion and collection of
0.7 ml of PBS, with help of a sterile 20G (1.1 mm diameter)
VialonTM intravenous catheter (Becton-Dickinson) inserted into
the trachea. An aliquot of each recovered BALF was serially
10-fold diluted in PBS, and plated on sBHI agar to determine
the number of viable bacteria. Results are expressed as mean
± SD of individual log10 c.f.u./BALF. In parallel, lungs were
removed; the left one was processed for viable bacterial counts
(as detailed above), and the right lung was fixed in 10%
neutral buffered formalin for histological purposes. Heads and
necks containing upper airways, larynx, and tracheas were
fixed in the same buffered formalin for histology. Uninfected
mice receiving PBS or TxS were used as controls when
necessary.
For cell counting, the remaining volume of each BALF sample
was centrifuged at 5,000 r.p.m. for 3 min at 4◦C. Each pellet was
resuspended in 1 ml RPMI 1640 with 10% FCS and Hepes 10
mM, and total cell count determined using a hemocytometer.
∼5x104 cells in 200 µl RPMI 1640 with 10% FCS and Hepes
10 mM were used for cytospin preparation (1,500 r.p.m. for
10 min at room temperature, Thermo Shandon Cytospin).
Giemsa stains were performed with an automated hematology
slide preparation unit (SP-10, Sysmex Cosporation) according
to the manufacturer’s instructions. Preparations were examined
in a double-blinded manner with an optical microscope (BX,
Olympus).
Histopathology and Lesion Score
Heads and necks were rinsed in running tap water for 1
h, immersed in 5% nitric acid for 24–36 h until complete
decalcification, and 7–8 transaxial slices were made every 3–4
mm beginning at the nostrils and finishing in the caudal tracheas.
Transaxial slices and lungs were embedded in paraffin, and 4–6
µm sections were stained with hematoxylin and eosin (H&E) by
standard procedures, and examined by microscopy to determine
the presence and extent of inflammatory lesions. Sections were
examined blind as sets by a trained veterinary pathologist (Dr.
M. Barberán). Parameters characterizing an acute inflammatory
reaction in upper airways, larynx, trachea, and lung, including
hemorrhages, hyperemia, polymorphonuclear cell infiltrates
(PMNs), and alveolar macrophages, were subjectively scored on a
scale of 0–3 (0: absent, 1: mild, 2: moderate, 3: severe). For tissue
control, similar organs obtained from non-infected control and
TxS treated mice were processed in an identical manner to the
infected tissues.
Statistical Analysis
For self-aggregation, gene expression, diameter of growth or
inhibition zones, PCho level, complement deposition, cell
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infection, bacterial loads in lungs and BALF samples, and
inflammatory cells in BALF samples, mean± SD were calculated
and statistical comparison of means performed using the two-
tail t-test. For histopathology scoring, means ± SD were also
calculated and statistical comparisons performed using one-way
analysis of variance (ANOVA) followed by Fisher’s protected
least significant difference (PLSD) multiple-comparison test. In
all cases, a p < 0.05 value was considered statistically significant.
Analyzes were performed using Prism software, version 6 forMac
(GraphPad Software) statistical package.
RESULTS
Isolation of a Thymidine Dependent NTHi
Strain from the Sputum of a COPD Patient
Receiving TxS
Among 2,542 clinical NTHi isolated between 2010 and 2014 at
Bellvitge University Hospital (Spain), 119 (4.7%) isolates formed
slow-growing colonies on MH-F agar. Thymidine auxotrophy
was screened on the 119 isolates by comparative growth on
chocolate agar and on low-thymidine MH-F agar. Thymidine
auxotrophy was confirmed by absence of bacterial growth on
MH-F agar, and further growth on MH-F agar in the presence
of discs soaked in thymidine. One thymidine auxotroph NTHi
isolate, named strain 8233, was identified in a sputum sample
recovered from a COPD patient who had received TxS for
36 days to treat an acute exacerbation by Stenotrophomonas
maltophilia. NTHi8233 produced small colonies on chocolate
agar (data not shown) and did not grow on MH-F agar,
except when discs soaked with thymidine 300 µg/ml or 10
mg/ml were added to the plate. Bacterial growth showed
to be dependent on thymidine concentration (Figure 1A).
The thymidylate synthase encoding gene thyANTHi8233 was
sequenced, and a 6 nt duplication 267GAAAAT rendering a
two-amino acid insertion (E90N91) was found, when compared
to that of the RdKW20 genome sequenced reference strain
(Fleischmann et al., 1995). A prediction of ThyAH.influenzae
tertiary structure, based on Burkholderia thailandensis ThyA
protein (PDB: 3V8H), was generated by the automated modeling
tool of the Swiss Model web service (http://swissmodel.expasy.
org). ThyANTHi8233 displayed 11 α-helices, 6 β-sheet strands
and several coil connecting segments (Figure S1A). Homology
between ThyANTHi8233 and ThyARdKW20 predicted structures is
shown by structural alignment (Figure S1D).
NTHi8233morphology was analyzed by confocal microscopy,
and showed non-septated bacterial filaments∼5–10 times longer
than the average NTHi bacteria (Figure 1A, right). The absence
of NTHi8233 growth on MH-F agar did not allow assessing its
antibiotic susceptibility following standard procedures (http://
www.eucast.org/clinical_breakpoints), and TxS resistance was
tested by E-test on bacteria grown on chocolate agar. The MIC
of TxS for NTHi8233 was >32 µg/ml. NTHi8233 thymidine
auxotrophy was found to be easily reversible, as described for
other pathogens (Kahl, 2014). Thymidine prototroph reverted
NTHi8233 strain did not present a filamented morphology (data
not shown) and the sequence of the thyA gene did not present
the 6 nt duplication described above, even though its MIC of TxS
remained unchanged.
Identification of NTHi8233 supports the notion that
thymidine auxotrophy may be a bacterial response to TxS
treatment that could be underestimated due to the lack of growth
on MH-F agar and given that, as previously stated for other
NTHi isolates (Platt et al., 1983), was shown to be reversible.
This observation prompted us to generate mutant strains
lacking the thyA gene on previously characterized NTHi genetic
backgrounds for a detailed study of the impact of thymidine
auxotrophy for this pathogen.
Generation and Characterization of
Thymidine Dependent H. influenzae strains
H. influenzae genome sequenced strains NTHi375 and RdKW20
were employed to generate thymidine dependent mutants by
disruption of the thyA gene (thyA accession numbers NF38_0045
and HI0905, respectively). At the protein level, ThyANTHi375
and ThyARdKW20 displayed 98.2% identity (Figure S1E). NTHi
mutants lacking the thyA gene were selected on sBHI agar
and rendered normal size colonies (data not shown), did not
grow on MH-F agar, and grew around discs soaked with
thymidine on MH-F agar. Growth was dependent on the
thymidine concentration present on the discs (Figure 1B and
Table 2). Thus, the thyA mutants displayed a larger growth zone
around discs soaked with thymidine 10 mg/ml than around
discs soaked with thymidine 300 µg/ml (NTHi3751thyA, p
< 0.005; RdKW201thyA, p < 0.05). In contrast, wild-type
(WT) bacteria presented a normal growth on MH-F agar. For
NTHi375 WT and 1thyA strains, the MICs of TxS were 0.25
and 0.38–0.5 µg/ml, respectively. For RdKW20 WT and thyA
mutant strains, the MICs of TxS were 0.12 and 0.5–0.75 µg/ml,
respectively. For purpose of illustration, larger growth inhibition
zones were observed for WT than for thyA mutant strains on
chocolate agar around TxS discs (Figure 1B). The morphology
of NTHi3751thyA and RdKW201thyA strains was assessed
by confocal microscopy, showing non-septated filaments longer
than their respective WT bacteria. Bacterial median length,
measured by TEM in ∼70 bacteria per strain, was (i) 1.42 ±
0.56 and 3.78 ± 2.86 µm for NTHi375 WT and 1thyA strains,
respectively (p < 0.0001); (ii) 1.43 ± 0.24 and 4.6 ± 4.98 µm for
RdKW20 WT and 1thyA strains, respectively (p < 0.0001). In
agreement, SEM showed enlarged thymidine dependent bacteria
on the surface of infected A549 human airway epithelial cells,
which may modify the infectious process, compared to that
shown by the WT strains (Figure 1B).
NTHi self-aggregates, which may promote microcolony
formation on host cell surfaces (Meng et al., 2011; Mell et al.,
2016). We asked whether the observed thymidine auxotrophy-
driven increased bacterial size differs in its self-aggregation, by
using tube-settling assays and monitoring the optical density
of bacterial suspensions over time. Thymidine dependent
mutants self-aggregated faster than their respective WT strains
(Figure 1C).
Together, inactivation of the thyA gene in NTHi (i) impaired
bacterial growth on MH-F agar, compensated by addition of
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FIGURE 1 | Thymidine auxotrophy modifies H. influenzae growth and morphology. (A) Growth of clinical isolate NTHi8233 on MH-F agar with sterile discs soaked in
water (1), thymidine 10 mg/ml, thymidine 300 µg/ml (3). Dotted circles indicate the growth zone around discs (left). A zoom of bacterial growth around a disc soaked
in thymidine 10 mg/ml is shown (middle). NTHi8233 morphology observed by SYTO 9 staining and confocal microscopy (scale bar, 10 µm; right). (B) Growth of
NTHi375 and RdKW20 WT and 1thyA strains on MH-F agar with sterile discs soaked in water (1), thymidine 10 mg/ml (2), thymidine 300 µg/ml (3). Bacterial growth
rendering a lawn switches color of the MH-F agar medium from red to brown. Dotted circles indicate the growth zone around thymidine discs; zooms of bacterial
growth around a disc soaked in thymidine 10 mg/ml are shown. Growth inhibition of NTHi375 and RdKW20 WT and 1thyA strains on chocolate agar around TxS
discs; dotted lanes indicate growth inhibition. Bacterial morphology observed by SYTO 9 staining and confocal microscopy (scale bar, 10 µm), TEM (scale bar, 2 µm;
magnification 25000×), and SEM (scale bar, 10 µm; magnification 6000×). In SEM panels, black arrows indicate infecting bacteria. (C) Effect of thymidine auxotrophy
on H. influenzae self-aggregation. Tube-settling experiment of bacterial cultures previously grown for 11 h on sBHI, after incubation at room temperature for 5 h. Left,
NTHi375 WT and 1thyA strains; right, RdKW20 WT and 1thyA strains; WT strains, black circle; 1thyA mutants, black square. Bacterial aggregation was quantified by
measuring the decrease of absorbance at OD600. The thyA mutants self-aggregated faster than their isogenic WT strains (for NTHi375, p < 0.05 at 1 and 2 h; for
RdKW20, p < 0.05 at 1 h, and p < 0.0005 at 2 h). All significant differences are indicated with *.
external thymidine, (ii) triggered enlarged bacilli which self-
aggregate faster than their isogenic WT strains, (iii) increased
resistance to TxS.
Thymidine Auxotrophy Causes Growth
Defects in H. influenzae
Growth in sBHI was analyzed for WT and thyA mutant strains.
NTHi3751thyA had an extended lag phase and lower final OD600
than the WT strain, which correlated with a reduced viability,
measured as c.f.u./ml at the indicated time points (Figure 2A).
Although not as pronounced, RdKW201thyA also had a slightly
extended lag phase and lower numbers of viable bacteria than
those of the WT strain (Figure 2B). In both thyA mutants,
the observed growth defects were partially restored by sBHI
supplementation with thymidine 300µg/ml, independently of its
addition in the pre-culture used for further dilution in sBHI and
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TABLE 2 | Bacterial growth in different media and conditions.
H. influenzae strain Chocolate
agar
MH-F
agar
Diameter of bacterial growth
on MH-F agar around Thya
disc (cm)
Thy 300 µg/ml Thy 10 mg/ml
NTHi375 Yes Yes Yes Yes
NTHi3751thyA Yes Nob 0.65 ± 0.05 1.83 ± 0.025
NTHi3751thyA+Thyc Yes No 1.25 ± 0.05 2.9 ± 0.1
RdKW20 Yes Yes Yes Yes
RdKW201thyA Yes No 0.9 ± 0.1 1.83 ± 0.08
RdKW201thyA+Thy Yes No 1.4 ± 0.1 3.35 ± 0.05
aThy, thymidine.
bTotal absence of bacterial growth.
cNTHi375∆thyA+Thy, bacteria previously grown on chocolate+Thy were used to
inoculate chocolate agar or MH-F agar plates.
OD600 recording, or in the actual sBHI culture used for growth
monitoring over time (Figures 2A,B). Immunofluorescence
microscopy at the final time point of the growth curve showed
non-septated long bacterial filaments for NTHi3751thyA grown
in sBHI, but a mixture of non-septated filaments and bacteria
with the average NTHi WT size for NTHi3751thyA pre-grown
in sBHI supplemented with thymidine 300 µg/ml (Figure 2A,
right). This could relate to the observed restoration of final
OD600 but not of final bacterial counts for NTHi3751thyA when
pre-cultured in sBHI supplemented with thymidine.
The thyA mutants, previously grown on chocolate agar
with thymidine (chocolate+Thy), grew on MH-F agar around
discs in a thymidine dependent manner, displaying a larger
growth zone around discs soaked with thymidine 10 mg/ml
than with thymidine 300 µg/ml (NTHi3751thyA, p < 0.005;
RdKW201thyA, p < 0.005). Of note, thyA mutants previously
grown on chocolate+Thy rendered a better growth on MH-
F agar around discs soaked in thymidine than that of the
same strains previously grown on chocolate agar (for thymidine
300 µg/ml, NTHi3751thyA, p < 0.05; for thymidine 10
mg/ml, NTHi3751thyA, p < 0.05, RdKW201thyA, p < 0.005;
Figures 1B, 2 bottom and Table 2). Similarly, external thymidine
(chocolate+Thy) rendered thyA bacterial length andmorphology
similar to those shown by their respective isogenic WT strains
(Figures 1B, 2 bottom).
Thymidine Auxotrophy Modifies the
Expression of the Nucleoside Transporter
Encoding nupC Gene in H. influenzae
Both thyA mutants growth on MH-F agar around discs
soaked in thymidine, and morphology/growth restoration in the
presence of external thymidine, prompted us to speculate that
these mutants may use external thymidine to overcome their
nucleoside dependency. It has been previously shown that the
nucleoside transporter encoding gene nupC is overexpressed
in S. aureus thymidine dependent-SCVs, and that a 1nupC
mutant fails to use external thymidine for growth under TxS
challenge (Chatterjee et al., 2008; Kriegeskorte et al., 2014).
HI0519 and NF38_02480 are annotated as nupC in the RdKW20
and NTHi375 genomes, respectively (Fleischmann et al., 1995;
Mell et al., 2014). Expression of the nupC gene in H. influenzae
was assessed by RT-qPCR, showing a trend to be higher in
the 1thyA than in their isogenic WT strains grown in sBHI,
with stronger evidence in NTHi375 (Figure S2A). As shown
in Figure 2, sBHI supplementation with thymidine partially
restored the growth defects shown by the thyA mutants.
Following the notion that thymidine supplementation may
restore mutant-related phenotypes, expression of the nupC gene
was analyzed in 1thyA bacteria when pre-cultured in sBHI
with thymidine and then grown in sBHI, or when grown
in sBHI supplemented with thymidine. Unexpectedly, when
mutant bacteria were pre-cultured in sBHI supplemented with
thymidine 300 µg/ml and then grown in sBHI, expression of
the nupC gene was even higher than when pre-cultured and
grown in sBHI (Figure S2A). Of note, a total absence of growth
inhibition was observed for thyA mutant strains on chocolate
agar around TxS discs, when pre-grown on chocolate+Thy (data
not shown).
Next, NTHi3751nupC and RdKW201nupC strains were
generated, showing growth rates comparable to those of their
respective WT strains in sBHI (Figure S2B), chocolate agar
and MH-F agar (data not shown). To assess the biological
function of nupC as a pyrimidine transporter responsible for
the uptake of extracellular thymidine in H. influenzae, we tested
the nupC mutants for their ability to use external thymidine
for growth under TxS challenge in a TxS disc diffusion assay.
Inhibition zones on chocolate agar and MH-F agar were
comparable for WT and 1nupC strains. Growth inhibition
around TxS discs was also tested on chocolate agar and MH-
F agar plates supplemented with thymidine. Unfortunately,
no conclusive differences were observed because, as already
described, bacterial growth on plates with high concentration of
thymidine may produce haze or fine growth areas (Lorian, 1996).
Following this notion, we performed a search for pyrimidine
transporters in all available genome sequenced H. influenzae
strains, which did not reveal the presence of nucleoside
transporters additional to NupC in this bacterial species. We
also unsuccessfully attempted to generate a NTHi double mutant
strain lacking both the thyA and nupC genes (data not shown),
further supporting a role for NupC in the uptake of external
thymidine.
Moreover, thymidylate is synthesized either by the
thymidylate synthase ThyA or by the thymidine kinase TK,
and inactivation of the former has been shown to result
in upregulated expression of the later one in Mycoplasma
pneumoniae (Wang et al., 2010). HI0529 and NF38_02430
are annotated as a tdk thymidine kinase in the RdKW20
and NTHi375 genomes, respectively (Fleischmann et al.,
1995; Mell et al., 2014). Different to nupC, the tdk gene
expression was shown to be similar in WT and 1thyA strains
grown in sBHI, independently of thymidine addition (Figure
S2C).
Together, these results suggest that nupCmay be a transporter
for external thymidine in H. influenzae, whose increased
expression could contribute to bypass the effects of TxS upon de
novo thymidylate biosynthesis.
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FIGURE 2 | H. influenzae growth is modified by thymidine availability. Bacterial growth, in the absence or presence of supplemented thymidine is shown for NTHi375
(A) and RdKW20 (B)WT and 1thyA strains. Growth in sBHI is shown as a means of OD600 (upper) and c.f.u./ml (middle) at the indicated time points. WT strains were
grown in sBHI (black circle); 1thyA strains were (i) grown in sBHI (black square), (ii) grown in sBHI+thymidine 300 µg/ml (inverted black triangle), (iii) pre-grown in
sBHI+thymidine 300 µg/ml and further diluted in sBHI for growth recording (white diamond). (A,B) bottom: growth of 1thyA mutants, pre-grown on chocolate agar
with thymidine 300 µg/ml (chocolate+Thy) and inoculated on MH-F agar with sterile discs soaked in water (1), thymidine 10 mg/ml (2), thymidine 300 µg/ml (3).
Dotted circles indicate the growth zone around discs; bacterial morphology is shown by SYTO 9 staining and confocal microscopy (scale bar, 10 µm).
Immunofluorescence microscopy at the final time point of the growth curve is shown for NTHi375 WT, 1thyA, and 1thyA pre-grown in sBHI supplemented with
thymidine 300 µg/ml (top, middle, and bottom images in A, right, respectively). Red arrows indicate the average NTHi WT size; green arrows indicate non-septated
bacterial filaments. Bacteria were labeled with rabbit anti-NTHi primary—and a donkey anti-rabbit conjugated to Cy2 secondary antibodies.
Thymidine Auxotrophy Reduces PCho
Expression and C3b Deposition in
H. influenzae
We have previously reported that bacteria lacking PCho
self-aggregate slightly faster (Morey et al., 2013). Thymidine
auxotroph mutants showed faster self-aggregation compared to
that of their WT strains (Figure 1C), which could relate to
changes in cellular morphology (i.e., elongation) or, alternatively,
to a different amount of PCho residues on the bacterial surface.
The level of PCho was measured on NTHi375 and RdKW20
WT and thyA mutant strains by flow cytometry using bacteria
grown in sBHI. Thymidine auxotrophy was associated with
a decreased detection of PCho in both NTHi3751thyA and
RdKW201thyAmutants, which was restored in NTHi3751thyA
by bacterial growth in sBHI in the presence of thymidine. Indeed,
PCho detection was higher in the thymidine dependent mutants
grown in sBHI supplemented with thymidine than in their
isogenic WT strains (Figure 3A and Figure S3A). Decreased
levels of PCho in the thyA mutants may modify the bacterial
ability to bind C-reactive protein (CRP; Weiser et al., 1998).
However, CRP deposition on the bacterial surface was similar
in WT and thyA mutant strains (Figure 3B and Figure S3B).
Finally, to assess the possibility that cellular morphology may
affect complement interaction, C3b deposition was analyzed.
Thymidine auxotrophy was associated with decreased detection
of C3b in NTHi3751thyA, which was restored by bacterial
growth in sBHI supplemented with thymidine (Figure 3C). No
differences were observed for C3b deposition between RdKW20
strains (Figure S3C).
Together, inactivation of the thyA gene caused a reduction in
the amount of PCho residues onH. influenzae surface, leading to
impaired C3b deposition in at least NTHi375, which suggests that
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FIGURE 3 | Thymidine auxotrophy reduces PCho level and C3b binding on
NTHi375. NTHi375 WT and 1thyA strains were exponentially grown in sBHI, in
the absence or presence of thymidine 300 µg/ml, and incubated with
anti-PCho (A), human serum and anti-CRP (B) or human serum and anti-C3b
(C) antibodies. Binding was analyzed by flow cytometry. Representative flow
cytometry histograms for each assay are shown (right). Color code: light gray,
control (CON) buffer; gray, NTHi375; black, NTHi3751thyA; dotted lane,
NTHi3751thyA grown in sBHI+Thy. NTHi3751thyA showed significantly lower
PCho level (p < 0.0001) and C3b deposition (p < 0.01) than the WT strain,
which was restored by mutant bacterial growth in sBHI with thymidine 300
µg/ml (PCho, p < 0.01; C3b, p < 0.01). PCho detection was significantly
higher in NTHi3751thyA grown in sBHI supplemented with thymidine than in
the WT strain (p < 0.05). *p < 0.05, **p < 0.01, ***p < 0.0001.
thymidine dependency may trigger changes affecting bacterial
recognition by this key complement component by a CRP-
independent mechanism.
Thymidine Auxotrophy Modifies
H. influenzae Interaction with Human
Airway Epithelia
The interplay of NTHi with the human respiratory epithelium
plays a determinant role in the progression of infection (Clementi
and Murphy, 2011). Next, we assessed if auxotrophy-related
bacterial morphology changes could alter such interplay, by
infecting A549 human type II pneumocytes with WT and thyA
mutant strains (Morey et al., 2011; Lopez-Gomez et al., 2012;
Euba et al., 2015c). Invasion by RdKW20 WT and thyA mutant
strains was not assayed given the poor invasiveness of this
genetic background (Mell et al., 2016). A549 cell adhesion and
invasion by NTHi3751thyA was lower than that shown by the
WT strain (Figure 4A). We also asked if external thymidine
could restore such deficiency by using mutant bacteria grown
in sBHI, in the absence or presence of thymidine (sBHI±Thy).
A549 cell adhesion of NTHi3751thyA grown in sBHI was
lower than that shown by the WT strain, which was restored
by thymidine addition (Figure 4A, right). Similar results were
obtained for RdKW201thyA grown in sBHI, when compared
to the WT strain, and to growth in sBHI with thymidine
(Figure S4A). Given the impaired host cell interaction due
to thymidine auxotrophy, we asked if inactivation of the
thyA gene modifies the epithelial cell inflammatory response
upon NTHi infection. Of note, the amount of secreted IL-
8 was higher in A549 cells infected by NTHi3751thyA than
by the WT strain, and such increase was reduced to WT
levels upon infection by NTHi3751thyA previously grown on
chocolate+Thy (Figure 4C). NTHi3751thyA lower epithelial
infection rate was also observed during infection of NCI H-292
human bronchial epithelial cells (Euba et al., 2015c), for both
adhesion and invasion (Figure 4B). NTHi3751thyA grown in
sBHI showed lower adhesion to NCI H-292 cells than the WT
strain, which was restored by thymidine supplementation, and
adhesion by NTHi3751thyA grown in sBHI+Thy was higher
than that shown by the WT strain (Figure 4B, right).
Complement opsonization, specifically C3, has been shown
to enhance the bacterium-epithelial cell interaction for poorly
encapsulated strains (de Astorza et al., 2004). Based on the
observed differential C3b deposition by NTHi375 WT and
1thyA strains, we next tested the effect of C3 in NTHi infection
of A549 cells. NTHi375 and NTHi3751thyA strains were grown
on chocolate agar (1thyA) or chocolate+Thy (1thyA+Thy), and
A549 cells were infected in the presence of human purified C3,
C3-deficient serum, or C3-deficient serum reconstituted with
human purified C3. The level of bacterial attachment did not
change in the presence of C3, compared to that observed in
control untreated cells (CON) or cells co-incubated with C3-
deficient serum (Figure S4B).
In summary, thymidine auxotrophy modified NTHi ability to
infect airway epithelial cells in terms of bacterial location and
triggered inflammatory response. Changes in adhesion and IL-
8 secretion could be restored by addition of external thymidine
in the bacterial growth medium. The presence of C3 at the onset
of infection did not modulate bacterial adhesion.
Inactivation of the thyA Gene Attenuates
H. influenzae Virulence and Confers
Advantage under TxS Treatment In vivo
Finally, we sought to determine the impact of thymidine
auxotrophy in vivo, by using a mouse NTHi respiratory infection
model system previously used for NTHi375 (Morey et al., 2013;
Euba et al., 2015a,b). Mice were infected with NTHi375 WT and
thyAmutant strains grown on chocolate agar, and bacterial loads
were quantified in lungs and BALF samples at 12, 24, and 48
hpi. In lungs, NTHi3751thyA bacterial numbers were lower than
those recovered for the WT strain at the three infection time
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FIGURE 4 | The thyA gene inactivation modulates H. influenzae interplay with cultured human airway epithelia. A549 type II pneumocytes (A) and NCI H-292
bronchial epithelial cells (B) were used to quantify adhesion and invasion by NTHi375 WT and 1thyA strains. For adhesion, infecting inocula were prepared by using
bacteria previously grown on chocolate agar following previously established methods (Morey et al., 2011; left). Alternatively, bacteria previously grown on sBHI, in the
absence or presence of thymidine (sBHI±Thy), were used (right). NTHi3751thyA showed significantly lower adhesion to A549 (chocolate agar, p < 0.005; sBHI, p <
0.005) and NCI H-292 (chocolate agar, p < 0.005; sBHI, p < 0.005) cells than the WT strain, which was restored by mutant pre-growth in sBHI with thymidine 300
µg/ml (A549, p < 0.05; NCI H-292, p < 0.005). NTHi3751thyA showed significantly lower entry into A549 (p < 0.005) and NCI H-292 (p < 0.005) cells than the WT
strain. (C) IL-8 release was higher in cells infected by NTHi3751thyA than by the WT strain (p < 0.005); NTHi3751thyA growth on chocolate+Thy reduced IL-8
secretion to WT levels (p < 0.005). *p < 0.05, **p < 0.005, ***p < 0.005.
points tested. Thymidine dependency was also associated with
significantly reduced bacterial counts in BALF at 12 and 24 hpi
(Figures 5A,B).
To further investigate if thymidine auxotrophy, despite
attenuation, confers an advantage to H. influenzae under TxS
treatment, we used a therapeutic regimen consisting of one TxS
dose (960 mg/kg, 1:5 TMP:SMX) every 6 h, starting at 6 hpi.
Results indicate that TxS treatment wasmore efficient in reducing
bacterial counts of the WT than of the thyAmutant strain. Thus,
a significant reduction of the WT population in lungs at 12, 24,
and 48 hpi, and BALF samples at 24 hpi, was observed under
treated—compared to that of untreated conditions. In contrast,
bacterial counts of NTHi3751thyA were unchanged at 12 and 24
hpi in both lungs and BALFs, despite TxS administration. The
protective effect of thyA mutation against TxS was not observed
at 48 hpi, maybe due to NTHi3751thyA severe clearance at this
post-infection time point.
Based on the differences observed at 24 hpi, we attempted
to restore the thyA mutant phenotypes by infecting with
mutant bacteria previously grown in the presence of thymidine.
However, intranasal inoculation of NTHi3751thyA grown on
chocolate+Thy did not restore bacterial counts, and lung
and BALF counts for NTHi375 WT were higher than those
obtained for 1thyA grown on chocolate+Thy. Unexpectedly,
NTHi3751thyA previous growth on chocolate+Thy increased
TxS efficiency, i.e., in TxS treated animals, lung, and BALF counts
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FIGURE 5 | Inactivation of the thyA gene attenuates H. influenzae virulence and confers advantage under TxS treatment in vivo. CD1 mice were infected with ∼2 ×
107 bacteria/mouse of NTHi375 WT (circle) or 1thyA (square) strains. When necessary, a therapeutic regimen consisting of 960 mg/kg TxS (1:5 TMP:SMX) was
administered orally each 6 h (dark symbols). Mice were euthanized at 12, 24, and 48 hpi, and bacterial loads were quantified in lungs (log10 c.f.u./lung) (A) and BALF
(log10 c.f.u./BALF) (B). NTHi3751thyA showed significantly lower loads in lungs and BALFs at 12 (lung, p < 0.001; BALF, p < 0.01), 24 (lung, p < 0.001; BALF, p <
0.001), and 48 (lung, p < 0.01) hpi than those shown by the WT strain. TxS administration significantly reduced WT strain recovery from lungs and BALF samples at
12 (lung, p < 0.05), 24 (lung, p < 0.001; BALF, p < 0.001), and 48 (lung, p < 0.001) hpi, compared to WT infected untreated mice. Inverted triangles: CD1 mice were
infected with ∼2 × 107 bacteria/mouse of 1thyA strain previously grown on chocolate+Thy for 16 h; when necessary, a therapeutic regime consisting of 960 mg/kg
TxS was administered orally each 6 h (dark inverted triangles). NTHi3751thyA previously grown on chocolate+Thy rendered significantly lower loads in lungs and
BALFs than the WT strain (p < 0.001); NTHi3751thyA previously grown on chocolate+Thy showed significantly lower loads in lungs and BALFs of TxS treated—than
in those of untreated mice (p < 0.001); in TxS treated mice, NTHi3751thyA previously grown on chocolate+Thy showed lower loads in lungs and BALFs than
NTHi3751thyA previously grown on chocolate agar (p < 0.01). (C) BALF samples were analyzed for PMN (left) and alveolar macrophage (M8; right) counts at 12 hpi.
Significantly higher numbers were observed in NTHi375 WT than in 1thyA infected samples for both PMN (p < 0.05) and M8s (p < 0.05). *p < 0.05, **p < 0.01,
***p < 0.001.
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were higher for NTHi3751thyA grown on chocolate agar than
for NTHi3751thyA grown on chocolate+Thy. Also, lung and
BALF counts for NTHi3751thyA grown on chocolate+Thy were
higher in untreated—than in TxS treated animals (Figures 5A,B).
Microscopy score of the average histopathological lesion
in samples of mice infected with WT or 1thyA strains was
also determined along the respiratory tract, and compared for
untreated and TxS-treated mice (Table 3). Histopathological
analysis of upper airways, larynxes, tracheas, and lungs from
mice intranasally infected with WT or with 1thyA rendered
inflammatory lesions. Lungs and airways from control mice
instilled with PBS did not show significant inflammation or
pathological changes, independently of TxS administration.
In both WT and 1thyA-infected mice, the upper airways
showed PMN infiltration of the lamina propria and lumens.
PMN infiltration was found in larger numbers in the lumens
of 1thyA infected mice than in those infected with WT
bacteria, at both 12 and 24 hpi. Conversely, PMN infiltration
of the upper airway lamina propria was found to be larger
in WT—than in 1thyA infected mice at 24 hpi. Mild PMN
infiltration of the lamina propria and lumens containing red
blood cells and PMNs were the main findings in larynxes
and tracheas. A tendency towards increased red blood cells
containing lumens in WT-infected compared to 1thyA infected
mice was apparent at 24 hpi, although the differences did
not reach statistical significance. As previously described (Euba
et al., 2015b), lungs in infected mice showed areas of acute
bronchopneumonia where alveolar septa were thickened with
edema and hyperemic septal capillaries. Neutrophils, alveolar
macrophages and scattered small hemorrhages were observed
in alveolar spaces. Comparison of scored lesions at 12 hpi
showed significantly more hemorrhages at the lower airway
of mice infected with WT than at those infected with 1thyA
bacteria in control untreated mice. Hemorrhages were also
found in larger proportions at the alveoli of mice infected
with NTHi375 at 12 than at 24 hpi, but a lower proportion
of alveolar macrophages was found at the lower airway of
mice infected with NTHi375 at 12 than at 24 hpi. Significant
differences were not found at the alveoli of 1thyA infected
mice between post-infection time points. Analysis of scored
lesions in the airways of WT infected mice showed differences
between control untreated- and TxS treated-mice. We observed
a higher proportion of PMN infiltration in (i) the upper airway
lumens at 24 hpi in TxS treated—than in control untreated
mice, and (ii) the alveoli in control untreated—than in TxS
treated mice at 12 hpi. Conversely, 1thyA infection caused
comparable lesions in both untreated- and TxS treated-mice
(Table 3). Intranasal inoculation of NTHi3751thyA previously
grown on chocolate+Thy rendered similar inflammatory lesions
in both untreated- and TxS treated-animals; as a sole difference, a
higher proportion of PMN infiltration was observed in the alveoli
of TxS treated—than of control untreated mice (p< 0.05).
Last, we quantified accumulation of immune cells in the
collected BALF samples at 12 hpi. NTHi375 WT pulmonary
infection increased the accumulation of PMNs and alveolar
macrophages, compared to that observed in the BALF of
1thyA infected mice. TxS treatment showed a trend to reduce
immune cell accumulation in BALF samples of WT infected
mice. Unexpectedly, TxS treatment increased immune cell
accumulation in BALF samples of1thyA infected mice (for both
PMNs and alveolar macrophages; Figure 5C).
In summary, thymidine auxotrophy reduces NTHi virulence
but, concomitantly, it confers an advantage under TxS treatment
in vivo, suggesting that uptake of external thymidine from the
infected tissue may contribute to bypass the bactericidal effect of
TxS. Moreover, overall higher inflammatory traits were observed
in WT—than in1thyA infected mice.
DISCUSSION
First-line antimicrobial agents must be effective, reliable, widely
available and affordable in resource-poor settings (Grant et al.,
2009). Following this notion, oral TxS has been recommended
for years as initial antibacterial for acute otitis media, non-
severe pneumonia or AECOPD because of its effectiveness
and reasonable price, which, in turn, has resulted in increased
resistance patterns by frequent respiratory pathogens such as
H. influenzae. Thus, H. influenzae increased TxS resistance
has been reported in clinical isolates from serotypes b, e, and
f, and non-typeable strains from various pathological origins
(Rowe et al., 2000; Leiberman et al., 2001; Campos et al.,
2003a,b; Arguedas et al., 2005; Mohd-Zain et al., 2012; Puig
et al., 2014; Greenhill et al., 2015). Besides H. influenzae TxS
resistance due to changes in the sequence and/or expression
of the folH and folP genes, or acquisition of the sul genes (de
Groot et al., 1988, 1996; Enne et al., 2002), TMP resistance
has been reported to arise in this pathogen as an indirect
result of mutation to thymidine/thymine auxotrophy (Platt et al.,
1983). Standard procedures for determination of H. influenzae
antibiotic susceptibility at diagnostic laboratories involve the
use of the low thymidine containing medium MH-F, which
could underestimate the frequency of thymidine-dependent
TMP/TxS resistance. Indeed, the routine evaluation of NTHi
clinical isolates carried out in this study reported a proportion
of strains designated as forming slow-growing colonies, which
prompted us to screen their thymidine dependency, leading to
identification of the thymidine auxotroph NTHi8233. Compared
to ThyARdKW20, ThyANTHi8233 has a two-amino acid insertion
at positions 90 and 91, which slightly modifies its predicted
structure (Figure S1). Inactive thyA gene alleles have been
reported for S. aureus due to in-frame deletions, deletions
resulting in a frameshift, or point mutations resulting in amino
acid transitions or non-sense mutations (Chatterjee et al.,
2008; Kriegeskorte et al., 2014). In this study, we identified
a NTHi thyA allele with an in-frame insertion compared to
previously genome sequenced strains, which could alter its
enzymatic activity. The ThyA canonical active site tryptophan
(W83) proposed for bacterial sequences (Baugh et al., 2013) is
conserved in ThyANTHi8233, and future work will attempt to
purify ThyANTHi8233 and further assess its thymidylate synthase
activity.
Moreover, NTHi8233 thymidine auxotrophy was found to be
reversible, and such reversion was associated to disappearance
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of the in-frame insertion in the thyANTHi8233 gene. This
transient phenotype, in agreement with previous observations
(Platt et al., 1983), prompts us to speculate that reversible
thymidine auxotrophy may lead into the infrequent isolation of
thymidine dependent NTHi strains from respiratory samples. In
contrast, TxS resistance level remained unchanged in NTHi8233,
independent of auxotrophy reversion. Of note, increased TMP
resistance has been previously found in H. influenzae thymidine
prototrophs isolated soon after isogenic thymidine auxotrophs
recovery from sputum samples exposed to subinhibitory TMP
concentrations, suggesting that TMP resistance could be the
result of a suppressor mutation (Platt et al., 1983). Following
this observation, the MIC of TMP for NTHi8233 was >32
µg/ml, independent of auxotrophy reversion. The mechanism(s)
underlying TMP/TxS resistance in NTHi8233 is currently
unknown and will be subject of future study.
Reversible thymidine auxotrophy has been widely shown for
S. aureus thymidine dependent-SCVs (Kahl, 2014), and made
NTHi8233 inadequate for analysis of the impact of thymidine
dependency on NTHi pathogenesis. For this purpose, the thyA
gene was inactivated in strains NTHi375 and RdKW20. NTHi
thyA mutants displayed alterations in morphology and growth,
and dependence on external thymidine, comparable to those
shown by S. aureus, Salmonella typhimurium, or S. maltophilia
thymidine auxotrophs (Kok et al., 2001; Kahl et al., 2003, 2005;
Anderson et al., 2007; Chatterjee et al., 2008). Moreover, NTHi
thyA gene disruption caused a reduced PCho level and C3b
deposition, impaired airway epithelial adhesion and invasion,
and enhanced secretion of IL-8 by cultured epithelial cells. In
some cases, minor phenotypic differences were observed between
NTHi375 and RdKW20 thyA mutants, likely to be related to the
known NTHi genomic heterogeneity (De Chiara et al., 2014).
Altogether, the observed in vitro phenotypes, such as a deficient
interaction with—and an increased inflammatory response by
cultured airway epithelial cells upon infection by 1thyA mutant
strains, are likely to contribute to NTHi thymidine auxotroph
attenuation upon murine lung infection. Modification of the
biology of infection due to thymidine auxotrophy has been
reported for other bacterial pathogens including S. aureus, S.
typhimurium, Shigella flexneri, or Vibrio cholerae (Attridge, 1995;
Cersini et al., 1998; Kok et al., 2001; Kriegeskorte et al., 2014).
We acknowledge that a limitation of this study is the lack of
genetic complementation for the thyA gene inactivation. Several
approaches were unsuccessfully undertaken for plasmid-encoded
thyARdKW20 gene complementation into RdKW201thyA, and
plasmid-encoded heterologous expression of the thyANTHi8233
allele into RdKW201thyA (data not shown). Of note, we
exclude a relationship between the thyA gene-related phenotypes
shown in this study and overexpression of the immediately
downstream gene, a putative homolog of the tadA gene encoding
a tRNA-specific adenosine deaminase, in the thyA mutants
(data not shown). Overexpression of the tadA gene has been
shown to confer resistance to the bactericidal natural product
xanthorrhizol in E. coli (Yogiara et al., 2015). Importantly,
addition of external thymidine in the growth media restored,
partial or totally, all analyzed in vitro phenotypes. Attenuation
of NTHi3751thyA in vivo was not restored by infecting bacteria
previously grown in the presence of external thymidine, which
could be due to the observed partial restoration of thymidine
prototrophy by available external thymidine, shown to be
dependent on thymidine concentration on MH-F agar.
In addition to the impact of thymidine auxotrophy by
inactivation of the thyA gene on NTHi virulence, TxS resistance
was shown to increase in the 1thyA mutant strains. Disruption
of the thyA gene has been related to increased TMP resistance
in other bacteria (Song et al., 2016). In agreement, the MIC
of TMP was 1 and >32 µg/ml for NTHi375 WT and 1thyA
strains, respectively, and was 0.75 and >32 µg/ml for RdKW20
WT and 1thyA strains, respectively. NTHi3751thyA pre-grown
in chocolate+Thy was cleared faster in TxS-treated than in
untreatedmice, and the reason(s) for this observation is currently
unknown. Although, originally intended to restore the observed
increased expression of the nupC gene upon thyA inactivation,
mutant pre-growth in sBHI with thymidine further amplified
nupC expression, compared to sBHI. It should be noted that
increased nupC gene expression by a thyA mutant in S. aureus
was previously restored by complementing thyA gene disruption
(Chatterjee et al., 2008). Our observation was unexpected and
formally incomparable to that made for S. aureus. We speculate
that it could be associated with the lack of growth inhibition
around TxS discs observed for thyA mutant strains when pre-
grown in chocolate+Thy, therefore suggesting that uptake of
external thymidine by the NupC nucleoside transporter could
contribute to circumvent the effects of TxS upon de novo
thymidylate biosynthesis in NTHi. We suggest here for the
first time that NupC could function as a primary thymidine
transporter in NTHi if de novo thymidylate synthesis is blocked.
Search in all available genome sequencedH. influenzae strains did
not reveal the presence of additional nucleoside transporters in
this bacterial species. As expected, we unsuccessfully attempted to
generate a NTHi double mutant strain lacking both the thyA and
nupC genes (data not shown), further supporting the proposed
role for NupC.
Three additional aspects deserve further discussion. First, S.
aureus thymidine dependent SCVs grow on Columbia blood agar
(Kriegeskorte et al., 2014); S. maltophilia thymidine dependent
SCVs grow on sheep blood-, brucella-, and chocolate-agar
(Anderson et al., 2007), but neither grow on MacConkey
agar and M9 minimal medium (Anderson et al., 2007), nor
S. typhimurium thyA mutants grow on LB agar (Kok et al.,
2001). Our results show that NTHi1thyA thymidine auxotrophs
grow rendering normal size colonies on chocolate—and sBHI-
agar, but fail to grow on MH-F agar. Therefore, we may not
consider the term thymidine dependent SCVs for H. influenzae.
Second, S. aureus SCVs are recovered from several human and
animal specimens, and are a highly dynamic subpopulation
optimized for persistence, enabling the bacteria to hide inside
the host cell without eliciting a strong host response (Kahl, 2014;
Kahl et al., 2016). This may be unlikely for NTHi thymidine
auxotrophs, given that we observed a significantly impaired
airway epithelial cell invasion by the NTHi3751thyA mutant
strain. Third, this study does not tackle the induction of NTHi
thymidine auxotrophy by TxS challenge, and we therefore cannot
speculate on the selection for thymine auxotrophs and TxS
resistance due to prolonged antibiotic exposure. Unexpectedly,
no statistically significant connection has been found between
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regional TxS use and resistance among H. influenzae isolates
(Karpanoja et al., 2008). We should also consider the potential
emergence of mutations in the thyA gene as a consequence of
treatment with other antibiotics with mutagenic activity such
as ciprofloxacin, which concomitantly increases TMP resistance
(Song et al., 2016). Hence, emergence of TxS resistance in
response to exposure to antibiotics needs further analysis and
continuous monitoring.
In conclusion, this study shows for the first time the impact
of thymidine auxotrophy by disruption of the thymidylate
synthase thyA on H. influenzae morphology and interplay with
the host airway and, indirectly, on its resistance to TxS. We
also show NupC as a potential facilitator of external thymidine
uptake upon inhibition of thymidylate de novo synthesis.
Thymidine auxotrophy lowers NTHi virulence, but also provides
an advantage under TxS exposure. Thus, our results should
be considered for the consequences of TxS administration
in the clinical settings. Further studies will contribute to
better assess the emergence of NTHi thymidine auxotrophs in
clinical samples, likely to be currently underestimated, and to
understand if NTHi thymidine dependency may be a response
to antibiotic treatment with a survival advantage in specific
environments.
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